Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:52 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Start: 2024-09-20. Completion: 2026-12-23 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
recombinant human follicle-stimulating hormone-CTP Fusion protein injection (drug)
recombinant human follicle-stimulating hormone-CTP Fusion protein injection Placebo (drug)
Where the study takes place — 17 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Anhui Children's Hospital Hefei, Anhui, China Site recruitment: Not reported
Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China Site recruitment: Not reported
Peking Union Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China Site recruitment: Not reported
The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China Site recruitment: Not reported
Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China Site recruitment: Not reported
Women and Children's Medical Center Affiliated to Guangzhou Medical University Guangzhou, Guangdong, China Site recruitment: Not reported
Shenzhen Children's Hospital Shenzhen, Guangdong, China Site recruitment: Not reported
Henan Children's Hospital Zhengzhou Children's Hospital Zhengzhou, Henan, China Site recruitment: Not reported
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China Site recruitment: Not reported
Nanjing Children's Hospital Nanjing, Jiangsu, China Site recruitment: Not reported
Jiangxi Children's Hospital Nanchang, Jiangxi, China Site recruitment: Not reported
Shengjing Hospital affiliated to China Medical University Shenyang, Liaoning, China Site recruitment: Not reported
Affiliated Hospital of Jining Medical College Jining, Shangdong, China Site recruitment: Not reported
Shanghai Children's Hospital Shanghai, Shanghai Municipality, China Site recruitment: Not reported
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China Site recruitment: Not reported
Affiliated Pediatric Hospital of Fudan University Shanghai, Shanghai Municipality, China Site recruitment: Not reported
Chengdu Women and Children's Central Hospital Chengdu, Sichuan, China Site recruitment: Not reported
Start: 2001-07-01. Completion: 2002-10-15 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Org 36286 (drug) — also listed as: Corifollitropin alpha
Puregon® (drug) — also listed as: recFSH
Orgalutran® (drug) — also listed as: ganirelix (Ganirelix Acetate Injection)
Pregnyl® (drug) — also listed as: human chorionic gonadatropin, hCG
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Illinois Hospital & Health Sciences System - IVF Program in the Fertility Center Chicago, Illinois, United States Site recruitment: Not reported
Start: 2021-03-22. Completion: 2023-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
NC (procedure)
mNC (procedure)
AC (procedure)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
My Duc Hospital Ho Chi Minh City, Vietnam Site recruitment: Not reported
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Sponsor
Cairo University
Countries with listed sites
Egypt
Registry dates and results
Start: 2020-01-01. Completion: 2024-01-31 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Gonadotropin (drug)
Letrozole (drug)
laparoscopic ovarian drilling (procedure)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
faculty of medicine, Kasr el ainy hospital, Cairo university Cairo, Egypt Site recruitment: Not reported
Ectopic Pregnancy; hCG; Pregnancy of Unknown Location
Sponsor
Acibadem University
Countries with listed sites
No country reported
Registry dates and results
Start: 2024-07-01. Completion: 2025-04-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
serum BHCG testing (diagnostic_test)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
RecFSH / Follitropin beta (Days 1 to 7) (biological) — also listed as: Puregon / Follistim AQ Cartridge
Placebo Corifollitropin alfa (drug)
Placebo RecFSH / follitropin beta (drug)
RecFSH / Follitropin beta (Days 8 to hCG) (biological) — also listed as: Puregon / Follistim AQ Cartridge
Ganirelix (drug) — also listed as: Orgalutran/ Ganirelix Acetate Injection
hCG (biological) — also listed as: Pregnyl / urinary hCG
Progesterone (biological)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
human Chorion Gonadotropin (hCG) (biological) — also listed as: Pregnyl®
hCG Bolus injection (biological) — also listed as: Pregnyl®
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2023-02-15. Completion: 2023-12-20 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
human chorionic gonadotropin (hCG) (drug)
Magnesium sulfate (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Mother and Child Care Hospital, Shaheed Zulfiqar Ali Bhutto Medical University Islamabad, Pakistan Site recruitment: Not reported
Start: 2013-02-11. Completion: 2015-04-08 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Corifollitropin alfa (drug) — also listed as: MK-8962
hCG (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Brazil · Denmark · Italy · Mexico · Russia · South Africa
Registry dates and results
Start: 2017-02-02. Completion: 2020-05-05 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Corifollitropin alfa (drug) — also listed as: MK-8962, Elonva
hCG (drug)
Where the study takes place — 15 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Centro de Diabetes Curitiba ( Site 0012) Curitiba, Brazil Site recruitment: Not reported
Hospital de Clinicas de Porto Alegre ( Site 0014) Porto Alegre, Brazil Site recruitment: Not reported
Hosp das Clinicas da Faculdade de Medicina da Univ de Sao Paulo ( Site 0015) São Paulo, Brazil Site recruitment: Not reported
Rigshospitalet, University department of Growth and Reproduction ( Site 0051) Copenhagen, Denmark Site recruitment: Not reported
AOU Careggi ( Site 0042) Florence, Italy Site recruitment: Not reported
Policlinico Umberto I ( Site 0043) Roma, Italy Site recruitment: Not reported
IRCCS Ospedale Pediatrico Bambino Gesu ( Site 0044) Roma, Italy Site recruitment: Not reported
Instituto Nacional de Pediatria ( Site 0007) Mexico City, Mexico Site recruitment: Not reported
Hospital Infantil de Mexico Federico Gomez ( Site 0006) Mexico City, Mexico Site recruitment: Not reported
Kazan State Medical University ( Site 0024) Kazan', Russia Site recruitment: Not reported
Federal State Budget Institution Endocrinological Research Center ( Site 0021) Moscow, Russia Site recruitment: Not reported
City children polyclinic #44 ( Site 0025) Saint Petersburg, Russia Site recruitment: Not reported
St.Petersburg State Pediatric Medical University ( Site 0023) Saint Petersburg, Russia Site recruitment: Not reported
Republic Children Clinical Hospital ( Site 0022) Ufa, Russia Site recruitment: Not reported
Little Company of Mary Hospital ( Site 0017) Pretoria, South Africa Site recruitment: Not reported
Start: 2019-10-01. Completion: 2022-10-01 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Corifollitoropin alfa (CFA)-double pick up (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
UZ Brussel Brussels, Jette, Belgium Site recruitment: Not reported
Start: 2024-05-01. Completion: 2025-08-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Shorten abstinence time (behavioral)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
the first hospital of Jilin University Changchun, Jilin, China Site recruitment: Recruiting
Start: 2021-05-26. Completion: 2024-04-22 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Vaginal swab (other)
Blood test (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
CHU de Nimes Nîmes, France Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Groupe Hospitalier Pellegrin-CHU de Bordeaux Bordeaux, France Site recruitment: Not reported
Hôpital Femme-Mère-Enfant (HCL) Bron, France Site recruitment: Not reported
CHU de Clermont-Ferrand - Hôpital Gabriel Montpied Clermont-Ferrand, France Site recruitment: Not reported
CHU Nord de Grenoble - Albert Michallon Grenoble, France Site recruitment: Not reported
Hôpital Claude Huriez Lille, France Site recruitment: Not reported
Hôpital de la Croix-Rousse (HCL) Lyon, France Site recruitment: Not reported
Hôpital Edouard Herriot (HCL) Lyon, France Site recruitment: Not reported
Hôpital Necker-Enfants malades Paris, France Site recruitment: Not reported
Hôpital Pitié-Salpêtrière Paris, France Site recruitment: Not reported
Hôpital Lyon Sud (HCL) Pierre-Bénite, France Site recruitment: Not reported
CHU de Saint-Etienne - Hôpital Nord Saint-Priest-en-Jarez, France Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Shanghai first Maternity and Infant health hospital, Tong Ji University Shanghai, China Site recruitment: Not reported
Start: 2023-01-01. Completion: 2024-05-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Recombinant Follicle Stimulating Hormone (drug)
Recombinant Follicle Stimulating Hormone and Clomiphene Citrate (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Bezmialem Vakif University Istanbul, Turkey (Türkiye) Site recruitment: Recruiting
Start: 2023-08-04. Completion: 2023-09-02 (may be estimated). No results posted in this registry response.
Products and interventions (0)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
First Teaching hospital of Tianjin University of Traditional Chinese Medicine Tianjin, China Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.